Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRGN-2009 + Neoadjuvant Chemotherapy in HPV-Associated Oropharyngeal Cancer
NCT06223568Phase 2Recruiting
- Sponsor
- National Cancer Institute
- Start
- Jun 2024
- Primary completion
- Jan 2028
- Modality
- Viral Vectors, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of PRGN-2009 in oropharyngeal squamous cell carcinoma (OPSCC), sponsored by National Cancer Institute. Started Jun 2024; status: recruiting.
02
Drugs
PRGN-2009
03
Conditions
oropharyngeal squamous cell carcinoma (OPSCC)
Beyond the preview
Go deeper on NCT06223568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06223568.